nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—PON1—cardiovascular system—Parkinson's disease	0.0615	0.156	CbGeAlD
Cefazolin—TPMT—Methylation Pathways—COMT—Parkinson's disease	0.0531	0.0878	CbGpPWpGaD
Cefazolin—TPMT—Methylation—COMT—Parkinson's disease	0.0488	0.0807	CbGpPWpGaD
Cefazolin—PON1—head—Parkinson's disease	0.0417	0.105	CbGeAlD
Cefazolin—PON1—nervous system—Parkinson's disease	0.0395	0.1	CbGeAlD
Cefazolin—PON1—central nervous system—Parkinson's disease	0.038	0.0963	CbGeAlD
Cefazolin—PON1—brain—Parkinson's disease	0.0302	0.0764	CbGeAlD
Cefazolin—TPMT—Phase II conjugation—GSTA4—Parkinson's disease	0.0171	0.0282	CbGpPWpGaD
Cefazolin—TPMT—medulla oblongata—Parkinson's disease	0.016	0.0405	CbGeAlD
Cefazolin—TPMT—midbrain—Parkinson's disease	0.0146	0.037	CbGeAlD
Cefazolin—TPMT—spinal cord—Parkinson's disease	0.0143	0.0361	CbGeAlD
Cefazolin—ABCC4—forebrain—Parkinson's disease	0.0133	0.0337	CbGeAlD
Cefazolin—TPMT—head—Parkinson's disease	0.0127	0.0321	CbGeAlD
Cefazolin—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.0121	0.02	CbGpPWpGaD
Cefazolin—TPMT—nervous system—Parkinson's disease	0.012	0.0304	CbGeAlD
Cefazolin—TPMT—central nervous system—Parkinson's disease	0.0116	0.0293	CbGeAlD
Cefazolin—TPMT—cerebellum—Parkinson's disease	0.0113	0.0286	CbGeAlD
Cefazolin—TPMT—Biological oxidations—GSTA4—Parkinson's disease	0.00999	0.0165	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00985	0.0163	CbGpPWpGaD
Cefazolin—TPMT—brain—Parkinson's disease	0.00918	0.0232	CbGeAlD
Cefazolin—SLC22A6—brain—Parkinson's disease	0.00915	0.0232	CbGeAlD
Cefazolin—TPMT—Biological oxidations—MAOB—Parkinson's disease	0.0089	0.0147	CbGpPWpGaD
Cefazolin—TPMT—Phase II conjugation—COMT—Parkinson's disease	0.00857	0.0142	CbGpPWpGaD
Cefazolin—TPMT—Phase II conjugation—GSTP1—Parkinson's disease	0.00853	0.0141	CbGpPWpGaD
Cefazolin—TPMT—Phase II conjugation—GSTM1—Parkinson's disease	0.00784	0.013	CbGpPWpGaD
Cefazolin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.00783	0.0129	CbGpPWpGaD
Cefazolin—ABCC4—head—Parkinson's disease	0.00762	0.0193	CbGeAlD
Cefazolin—SLC22A8—head—Parkinson's disease	0.00756	0.0191	CbGeAlD
Cefazolin—ABCC4—nervous system—Parkinson's disease	0.00722	0.0183	CbGeAlD
Cefazolin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.00721	0.0119	CbGpPWpGaD
Cefazolin—SLC22A8—nervous system—Parkinson's disease	0.00716	0.0181	CbGeAlD
Cefazolin—ABCC4—central nervous system—Parkinson's disease	0.00695	0.0176	CbGeAlD
Cefazolin—SLC22A8—central nervous system—Parkinson's disease	0.0069	0.0175	CbGeAlD
Cefazolin—ABCC4—ABC-family proteins mediated transport—ABCB1—Parkinson's disease	0.00665	0.011	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—CYP2D6—Parkinson's disease	0.00662	0.0109	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00653	0.0108	CbGpPWpGaD
Cefazolin—ABCC4—Fluoropyrimidine Activity—MTHFR—Parkinson's disease	0.00611	0.0101	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—CYP2E1—Parkinson's disease	0.00605	0.01	CbGpPWpGaD
Cefazolin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.00597	0.00987	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00597	0.00987	CbGpPWpGaD
Cefazolin—ALB—brain—Parkinson's disease	0.0057	0.0144	CbGeAlD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—DGKQ—Parkinson's disease	0.00558	0.00923	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—SNCA—Parkinson's disease	0.00553	0.00915	CbGpPWpGaD
Cefazolin—ABCC4—brain—Parkinson's disease	0.00552	0.014	CbGeAlD
Cefazolin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.0055	0.00909	CbGpPWpGaD
Cefazolin—SLC22A8—brain—Parkinson's disease	0.00548	0.0139	CbGeAlD
Cefazolin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.00514	0.00849	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—FGB—Parkinson's disease	0.00512	0.00846	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—COMT—Parkinson's disease	0.00502	0.00829	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—GSTP1—Parkinson's disease	0.00499	0.00825	CbGpPWpGaD
Cefazolin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.00499	0.00824	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—MAOA—Parkinson's disease	0.00498	0.00823	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—COMT—Parkinson's disease	0.00495	0.00818	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00492	0.00814	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—FGB—Parkinson's disease	0.00487	0.00806	CbGpPWpGaD
Cefazolin—ALB—HDL-mediated lipid transport—APOE—Parkinson's disease	0.00484	0.008	CbGpPWpGaD
Cefazolin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.00459	0.00758	CbGpPWpGaD
Cefazolin—TPMT—Biological oxidations—GSTM1—Parkinson's disease	0.00459	0.00758	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—GSTA4—Parkinson's disease	0.00459	0.00758	CbGpPWpGaD
Cefazolin—TPMT—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00452	0.00748	CbGpPWpGaD
Cefazolin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.00392	0.00648	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—SOD1—Parkinson's disease	0.0038	0.00628	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—Parkinson's disease	0.00362	0.00598	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—IGF2—Parkinson's disease	0.00361	0.00596	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00356	0.00588	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—INSR—Parkinson's disease	0.00351	0.00581	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF2—Parkinson's disease	0.00344	0.00568	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00341	0.00563	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00341	0.00563	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—HGF—Parkinson's disease	0.00341	0.00563	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00328	0.00541	CbGpPWpGaD
Cefazolin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.00327	0.0054	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ND3—Parkinson's disease	0.00325	0.00538	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MCCC1—Parkinson's disease	0.00325	0.00538	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—HGF—Parkinson's disease	0.00325	0.00537	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MERTK—Parkinson's disease	0.00323	0.00534	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—DOCK3—Parkinson's disease	0.00323	0.00534	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—TALDO1—Parkinson's disease	0.00306	0.00506	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—OMD—Parkinson's disease	0.00306	0.00506	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NDUFB11—Parkinson's disease	0.0029	0.00479	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—DGKQ—Parkinson's disease	0.00288	0.00476	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—INSR—Parkinson's disease	0.00286	0.00472	CbGpPWpGaD
Cefazolin—ALB—Lipoprotein metabolism—APOE—Parkinson's disease	0.00278	0.0046	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GCH1—Parkinson's disease	0.00277	0.00457	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—NQO1—Parkinson's disease	0.00275	0.00454	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—HSPA1A—Parkinson's disease	0.00273	0.00451	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00271	0.00449	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—SLC6A3—Parkinson's disease	0.00271	0.00448	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.0026	0.0043	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.0026	0.0043	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—DGKQ—Parkinson's disease	0.00253	0.00418	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.0025	0.00413	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00249	0.00412	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00249	0.00412	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GBA—Parkinson's disease	0.00246	0.00407	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—FBP1—Parkinson's disease	0.00246	0.00407	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—DBH—Parkinson's disease	0.00246	0.00407	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—SOD1—Parkinson's disease	0.00246	0.00407	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00233	0.00386	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—FGB—Parkinson's disease	0.00232	0.00383	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—GSTP1—Parkinson's disease	0.00229	0.00379	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—INSR—Parkinson's disease	0.00227	0.00375	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.00227	0.00375	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00227	0.00375	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—HMOX1—Parkinson's disease	0.00226	0.00374	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—SOD2—Parkinson's disease	0.00222	0.00367	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—FGB—Parkinson's disease	0.00221	0.00365	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00217	0.00359	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00217	0.00359	CbGpPWpGaD
Cefazolin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—Parkinson's disease	0.00217	0.00358	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—GSTM1—Parkinson's disease	0.00211	0.00348	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—HGF—Parkinson's disease	0.00211	0.00348	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00208	0.00345	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—SOD1—Parkinson's disease	0.002	0.00331	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—MTHFR—Parkinson's disease	0.00195	0.00323	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MAG—Parkinson's disease	0.00185	0.00307	CbGpPWpGaD
Cefazolin—ALB—Lipid and lipoprotein metabolism—APOE—Parkinson's disease	0.00185	0.00305	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—APOE—Parkinson's disease	0.00182	0.00301	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—DDC—Parkinson's disease	0.00181	0.00299	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00181	0.00299	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—SOD2—Parkinson's disease	0.00181	0.00298	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00178	0.00294	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—INS—Parkinson's disease	0.00175	0.00289	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—GPX1—Parkinson's disease	0.00172	0.00285	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—SOD1—Parkinson's disease	0.00172	0.00284	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTA4—Parkinson's disease	0.00171	0.00282	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.00168	0.00279	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00166	0.00275	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—Parkinson's disease	0.00164	0.00271	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—IGF2—Parkinson's disease	0.00163	0.0027	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.0016	0.00265	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.00159	0.00263	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—MTHFR—Parkinson's disease	0.00159	0.00263	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—Parkinson's disease	0.00156	0.00257	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—INS—Parkinson's disease	0.00155	0.00257	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—HGF—Parkinson's disease	0.00154	0.00255	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PLA2G6—Parkinson's disease	0.00154	0.00254	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MAOB—Parkinson's disease	0.00152	0.00252	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.00151	0.0025	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00149	0.00246	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Parkinson's disease	0.00147	0.00243	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—DOCK3—Parkinson's disease	0.00146	0.00242	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MERTK—Parkinson's disease	0.00146	0.00242	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.00143	0.00237	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00138	0.00228	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.00137	0.00226	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00132	0.00219	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—DGKQ—Parkinson's disease	0.0013	0.00215	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00127	0.0021	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—INS—Parkinson's disease	0.00126	0.00209	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00126	0.00209	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00122	0.00201	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00119	0.00196	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00118	0.00195	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—FGB—Parkinson's disease	0.00117	0.00193	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL1B—Parkinson's disease	0.00116	0.00192	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00115	0.0019	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00114	0.00188	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP2D6—Parkinson's disease	0.00113	0.00187	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00113	0.00186	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00113	0.00186	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CTGF—Parkinson's disease	0.00111	0.00184	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00108	0.00179	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00106	0.00175	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP2E1—Parkinson's disease	0.00104	0.00171	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.00103	0.0017	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NQO1—Parkinson's disease	0.00102	0.00169	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—TH—Parkinson's disease	0.00101	0.00167	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00101	0.00167	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—INS—Parkinson's disease	0.001	0.00166	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00099	0.00164	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYCS—Parkinson's disease	0.000968	0.0016	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00095	0.00157	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL1B—Parkinson's disease	0.000943	0.00156	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000904	0.0015	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SOD1—Parkinson's disease	0.000868	0.00144	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000868	0.00144	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000867	0.00143	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—COMT—Parkinson's disease	0.000858	0.00142	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTP1—Parkinson's disease	0.000854	0.00141	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MAOA—Parkinson's disease	0.000852	0.00141	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—HMOX1—Parkinson's disease	0.000842	0.00139	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.000841	0.00139	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MAG—Parkinson's disease	0.000839	0.00139	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000832	0.00138	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ABL1—Parkinson's disease	0.000829	0.00137	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IGF2—Parkinson's disease	0.000825	0.00136	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ABCB1—Parkinson's disease	0.000808	0.00134	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTM1—Parkinson's disease	0.000784	0.0013	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HGF—Parkinson's disease	0.000779	0.00129	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000772	0.00128	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.000762	0.00126	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000755	0.00125	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000755	0.00125	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GPX1—Parkinson's disease	0.000751	0.00124	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000749	0.00124	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000725	0.0012	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000724	0.0012	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.000724	0.0012	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000724	0.0012	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000695	0.00115	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MTHFR—Parkinson's disease	0.000693	0.00115	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TNF—Parkinson's disease	0.000684	0.00113	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.000684	0.00113	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.000679	0.00112	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—APOE—Parkinson's disease	0.000645	0.00107	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00063	0.00104	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000629	0.00104	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000605	0.001	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000598	0.000989	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ND3—Parkinson's disease	0.000593	0.00098	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MCCC1—Parkinson's disease	0.000593	0.00098	CbGpPWpGaD
Cefazolin—ALB—Metabolism—OMD—Parkinson's disease	0.000557	0.000921	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TALDO1—Parkinson's disease	0.000557	0.000921	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—Parkinson's disease	0.000552	0.000913	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—INS—Parkinson's disease	0.000551	0.000912	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000551	0.00091	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000544	0.000899	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FGB—Parkinson's disease	0.000529	0.000875	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NDUFB11—Parkinson's disease	0.000528	0.000873	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GCH1—Parkinson's disease	0.000504	0.000833	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000454	0.000751	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GBA—Parkinson's disease	0.000449	0.000742	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FBP1—Parkinson's disease	0.000449	0.000742	CbGpPWpGaD
Cefazolin—ALB—Metabolism—DBH—Parkinson's disease	0.000449	0.000742	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000439	0.000725	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SOD1—Parkinson's disease	0.000393	0.00065	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000392	0.000649	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000377	0.000623	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ABL1—Parkinson's disease	0.000375	0.00062	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IGF2—Parkinson's disease	0.000373	0.000617	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HGF—Parkinson's disease	0.000352	0.000583	CbGpPWpGaD
Cefazolin—ALB—Metabolism—DDC—Parkinson's disease	0.00033	0.000545	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000327	0.000541	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000314	0.00052	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA4—Parkinson's disease	0.000311	0.000515	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000307	0.000508	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PLA2G6—Parkinson's disease	0.00028	0.000463	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MAOB—Parkinson's disease	0.000277	0.000459	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000264	0.000437	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2D6—Parkinson's disease	0.000206	0.000341	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CTGF—Parkinson's disease	0.000202	0.000335	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2E1—Parkinson's disease	0.000189	0.000312	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NQO1—Parkinson's disease	0.000186	0.000308	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TH—Parkinson's disease	0.000184	0.000304	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYCS—Parkinson's disease	0.000176	0.000292	CbGpPWpGaD
Cefazolin—ALB—Metabolism—COMT—Parkinson's disease	0.000156	0.000258	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTP1—Parkinson's disease	0.000156	0.000257	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MAOA—Parkinson's disease	0.000155	0.000257	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMOX1—Parkinson's disease	0.000153	0.000254	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCB1—Parkinson's disease	0.000147	0.000243	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTM1—Parkinson's disease	0.000143	0.000236	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPX1—Parkinson's disease	0.000137	0.000226	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTHFR—Parkinson's disease	0.000126	0.000209	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APOE—Parkinson's disease	0.000118	0.000194	CbGpPWpGaD
Cefazolin—ALB—Metabolism—INS—Parkinson's disease	0.0001	0.000166	CbGpPWpGaD
